3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
28
Dermatologic
5
Thoracic
4
Breast
3
Gynecologic
2
Genitourinary
2
Gastrointestinal
2
CNS
2
Sarcoma
1
Other neoplasm
1
NET
1
Endocrine
1
Conditions
Sarcoma
18
Osteosarcoma
7
Neoplasm Metastasis
6
Lymphoma, Non-Hodgkin
6
Glioma
6
Ependymoma
6
Carcinosarcoma
6
Rhabdomyosarcoma
5
Neuroblastoma
5
Medulloblastoma
5
Liposarcoma
5
Leiomyosarcoma
5
Central Nervous System Neoplasms
5
Neuroectodermal Tumors, Primitive, Peripheral
4
Lymphoma, Follicular
4
Histiocytosis, Langerhans-Cell
4
Histiocytoma, Malignant Fibrous
4
Gliosarcoma
4
Glioblastoma
4
Endometrial Neoplasms
4
Wilms Tumor
3
Sarcoma, Kaposi
3
Rhabdoid Tumor
3
Prostatic Neoplasms
3
Oligodendroglioma
3
Melanoma
3
Lymphoma, B-Cell, Marginal Zone
3
Lung Neoplasms
3
Leukemia, Lymphocytic, Chronic, B-Cell
3
Hepatoblastoma
3
Interventions
pembrolizumab
11
Nivolumab
4
Erlotinib Hydrochloride
3
Docetaxel
3
Cetuximab
3
Capecitabine
3
tislelizumab
2
spartalizumab
2
Specimen Handling
2
Magnetic Resonance Spectroscopy
2
Immunoglobulin G
2
Gemcitabine
2
Filgrastim
2
Cyclophosphamide
2
tremelimumab
1
sargramostim
1
ribociclib
1
poly ICLC
1
pexidartinib
1
mirabegron
1
futibatinib
1
etoposide phosphate
1
entinostat
1
durvalumab
1
ciforadenant
1
cemiplimab
1
capivasertib
1
bempegaldesleukin
1
avelumab
1
X-Rays
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Squamous Cell Carcinoma of Head and Neck
×
Biopsy
×
Sarcoma
×
Clear all
NCT05269381
2026-03-12
PNeoVCA
Mayo Clinic
Phase 1/2
Recruiting
132 enrolled